Denmark-headquartered Novo Nordisk, a leading global healthcare company founded in 1923 to drive change to defeat serious chronic diseases built upon our heritage in diabetes, announced headline ...

The combination works by decreasing hunger and increasing the feeling of fullness. The REDEFINE 2 trial (ClinicalTrials.gov Identifier: NCT05394519) evaluated the efficacy and safety of CagriSema in ...

The combination works by decreasing hunger and increasing the feeling of fullness. The REDEFINE 2 trial (ClinicalTrials.gov Identifier: NCT05394519) evaluated the efficacy and safety of CagriSema ...

Denmark: CagriSema has demonstrated superior weight loss in adults with obesity or overweight and type 2 diabetes in the REDEFINE 2 trial, Novo Nordisk said in a release. The headline results from ...

New Zealand lawmakers have dealt an overwhelming defeat to a controversial proposed law seeking to redefine the country’s ...

Discover the Nintendo Switch 2: release date, hardware upgrades, retro gaming, and game lineup. Everything you need to know ...

Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt ...

With the rise of online lobbies and the disappearance of couch co-op (a staple of yours truly growing up in the 1990s), ...

As the spring season blooms, many women over 60 are embracing an exciting chapter in their fashion journey. This stage in ...

It’s ambiguous whether the Klarna IPO will be a catalyst for further high profile fintech IPOs. According to S&P Global ...